We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





SARS-CoV-2 Acts as Sponge to Delete Specific Host microRNAs, Making it More Dangerous than Other Coronaviruses

By HospiMedica International staff writers
Posted on 24 Aug 2020
Print article
Illustration
Illustration
A team of researchers have proposed that the SARS-CoV-2 virus is more deadly than many other coronaviruses because the COVID-19 virus acts as a microRNA “sponge.” This action modulates host microRNA levels in ways that aid viral replication and stymies the host immune response.

Researchers from the University of Alabama at Birmingham (Birmingham, AL, USA) and Poland have proposed this testable hypothesis results based on their analysis of current literature and a bioinformatic study of the COVID-19 virus and six other coronaviruses.

Human microRNAs, or miRNAs, are short, non-coding RNAs with about 22 bases that act to regulate gene expression by their complementary pairing with specific messenger RNAs of the cell. That pairing silences the messenger RNA, preventing it from being translated into a protein. Thus, miRNAs are a fine-tuned controller of cell metabolism or the cell’s response to stress and adverse challenges, like infection by a virus. The miRNAs are only about 0.01% of total human cell and tissue RNA, while replicating viral RNA of a virus like the COVID-19 virus may reach 50% of the total cellular RNA. Hence, the UAB and Polish researchers believe that if the COVID-19 virus has binding sites for specific miRNAs - and these sites are different from the binding sites for miRNAs found on coronaviruses that cause colds - the more pathogenic COVID-19 virus may selectively sponge up certain miRNAs to dysregulate the cell in ways that make it a dangerous human coronavirus. The two human coronaviruses prior to the COVID-19 virus - the severe acute respiratory coronavirus, or SARS virus, and the Middle East respiratory syndrome coronavirus, or MERS virus, - were both dangerous, but did not have the high infectivity of the SARS-CoV-2 virus, which causes COVID-19.

For their study, the researchers used computer-aided bioinformatic analysis to find potential miRNA target sites for 896 mature human miRNA sequences on seven different coronavirus genomes. These genomes included the three pathogenic coronaviruses - the SARS, MERS and COVID-19 viruses - and four non-pathogenic coronaviruses. The researchers found that the number of target sites was elevated in the pathogenic viruses compared to the non-pathogenic strains. Furthermore, they found that pathogenic human coronaviruses attracted sets of miRNAs that differ from the non-pathogenic human coronaviruses. In particular, a set of 28 miRNAs were unique for the COVID-19 virus; the SARS and MERS viruses had their own unique sets of 21 and 24 miRNAs, respectively.

Focusing on the 28 unique miRNAs for the COVID-19 virus, the researchers found that the majority of these miRNAs are well expressed in bronchial epithelial cells, and their dysregulation has been reported in human lung pathologies that include lung cancers, chronic obstructive pulmonary disease, cystic fibrosis and tuberculosis. Furthermore, many of the miRNAs have been proposed to act as tumor suppressors that target the pathways for programmed cell death, or apoptosis, that are supposed to make a cell kill itself when infected, mutated or stressed in other ways. Reduction of those miRNAs has been associated with poor cancer prognosis.

“Hence, the COVID-19 virus - by its potential reduction of the host’s miRNA pool - may promote infected cell survival and thus continuity of its replication cycle,” the researchers said.

Related Links:
University of Alabama at Birmingham

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
LED Surgical Light
Convelar 1670 LED+/1675 LED+/1677 LED+
New
Medical-Grade POC Terminal
POC-821

Print article

Channels

Surgical Techniques

view channel
Image: The new treatment combination for subdural hematoma reduces the risk of recurrence (Photo courtesy of Neurosurgery 85(6):801-807, December 2019)

Novel Combination of Surgery and Embolization for Subdural Hematoma Reduces Risk of Recurrence

Subdural hematomas, which occur when bleeding happens between the brain and its protective membrane due to trauma, are common in older adults. By 2030, chronic subdural hematomas are expected to become... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.